Related Experiment Video
Updated: Nov 19, 2025
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
An elementary mathematical modeling of drug resistance in cancer
1School of Mathematics and Statistics, Central China Normal University, Wuhan 430079, China.
Abstract:
Targeted therapy is one of the promising strategies for the treatment of cancer. However, resistance to anticancer drug strongly limits the long-term effectiveness of treatment, which is a major obstacle for successfully treating cancer. In this paper, we analyze a linear system of ordinary differential equations for cancer multi-drug resistance induced mainly by random genetic point mutation. We investigate that the resistance generated before the beginning of the treatment is greater than that developed during-treatment. This result depends on the concentration of the drug, which holds only when the concentration of the drug reaches a lower limit. Moreover, no matter how many drugs are used in the treatment, the amount of resistance (generated at the beginning of the treatment and within a certain period of time after the treatment) always depends on the turnover rate. Using numerical simulations, we also evaluate the response of the mutant cancer cell population as a function of time under different treatment strategies. At appropriate dosages, combination therapy produces significant effects for the treatment with low-turnover rate cancer. For cancer with very high-turnover rate (close to 1), combination therapy can not significantly reduce the amount of resistant mutants compared to monotherapy, so in this case, combination therapy would not have advantage over monotherapy.
Insights
Pre-existing cancer drug resistance is higher than treatment-induced resistance, influenced by drug concentration and cell turnover rates. Combination therapy is effective for low-turnover cancers but not high-turnover ones.
Area of Science:
- Oncology
- Mathematical Biology
- Pharmacology
Background:
- Targeted therapy offers promise for cancer treatment.
- Anticancer drug resistance significantly hinders long-term treatment effectiveness.
- Understanding resistance mechanisms is crucial for overcoming treatment obstacles.
Purpose of the Study:
- To analyze cancer multi-drug resistance using a linear system of ordinary differential equations.
- To compare pre-treatment resistance versus during-treatment resistance.
- To evaluate the impact of drug concentration and turnover rate on resistance development.
Main Methods:
- Analysis of a linear system of ordinary differential equations.
- Mathematical modeling of cancer multi-drug resistance.
- Numerical simulations to assess treatment strategy responses.
Main Results:
- Pre-treatment resistance exceeds during-treatment resistance, contingent on drug concentration reaching a lower limit.
- Cancer resistance is consistently dependent on turnover rate, irrespective of the number of drugs used.
- Combination therapy shows efficacy for low-turnover rate cancers but offers no significant advantage over monotherapy for very high-turnover rate cancers.
Conclusions:
- Drug concentration and cell turnover rate are critical factors in cancer resistance.
- Treatment strategies, including combination therapy, must consider cancer-specific turnover rates for optimal outcomes.
- The timing of resistance development (pre-treatment vs. during-treatment) impacts overall therapeutic effectiveness.
Related Concept Videos
02:56Treatment Resistant Cancers
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
01:21Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs
On the other hand, integral calculus focuses on...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:20Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
01:19Fundamental Mathematical Principles in Pharmacokinetics: Mathematical Expressions and Units
One significant application of mathematics in pharmacokinetics is the characterization of drug distribution through the volume of distribution...